Failure to Warn Claims Survive as Makers of Xarelto Denied Summary Judgment

With more than 16,000 Xarelto bleeding lawsuits pending in the Eastern District of Louisiana, two motions for partial summary judgment have been denied by U.S. District Judge Eldon Fallon, the judge presiding over the Xarelto multidistrict litigation, or MDL. The motions were filed by manufacturers of the blood-thinner drug, Johnson & Johnson subsidiary Janssen Pharmaceuticals, seeking to dismiss claims that it failed to warn consumers about the risk of severe bleeding problems associated with Xarelto. Judge Fallon’s denial of these motions allows two pending bellwether cases to proceed. The bellwether cases are scheduled to go to trial on April 30, 2017 and May 30, 2017.

Many plaintiffs in the Xarelto litigation are represented by Grant & Eisenhofer, a plaintiffs’ firm involved in the Bellwether Selection Committee and co-lead of the Law & Briefing Committee. If you or a loved one experienced complications from taking the drug Xarelto, please call us at (888) 984-7988 for a confidential evaluation of your potential claim.

Real Time Analytics